Novel Frataxin Isoforms May Contribute to the Pathological Mechanism of Friedreich Ataxia

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Xia, Haiyan ^a,b   Cao, Yun ^a   Dai, Xiaoman ^a   Marelja, Zvonimir ^c   Zhou, Di ^a   Mo, Ran ^a   Al Mahdawi, Sahar ^d   Pook, Mark A ^d   Leimkühler, Silke ^c   Rouault, Tracey A ^e   Li, Kuanyu ^a,b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c UNIVERSITY OF POTSDAM   (Germany)

^d BRUNEL UNIVERSITY   (United Kingdom)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; FRATAXIN; FRATAXIN ISOFORM I; FRATAXIN ISOFORM II; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FIBROBLAST; FRIEDREICH ATAXIA; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; LYMPHOBLAST; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED, 80 AND OVER; AMINO ACID SEQUENCE; CELL LINE; CENTRAL NERVOUS SYSTEM; FEMALE; FRIEDREICH ATAXIA; GENE EXPRESSION REGULATION; HUMANS; IRON-BINDING PROTEINS; IRON-SULFUR PROTEINS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYOCARDIUM; ORGAN SPECIFICITY; PROTEIN ISOFORMS; PROTEIN TRANSPORT; RNA, MESSENGER;

EID: 84867637537     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047847     Document Type: Article

References (44)

1. Koeppen AH, (2011) Friedreich's ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci 303: 1-12.
2. Stemmler TL, Lesuisse E, Pain D, Dancis A, (2010) Frataxin and mitochondrial FeS cluster biogenesis. J Biol Chem 285: 26737-26743.
3. Marmolino D, (2011) Friedreich's ataxia: past, present and future. Brain Res Rev 67: 311-330.
4. Kumari D, Usdin K, (2012) Is Friedreich ataxia an epigenetic disorder? Clin Epigenetics 4: 2.
5. Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, et al. (2006) Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol 2: 551-558.
6. Rai M, Soragni E, Jenssen K, Burnett R, Herman D, et al. (2008) HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS One 3: e1958.
7. Acquaviva F, De Biase I, Nezi L, Ruggiero G, Tatangelo F, et al. (2005) Extra-mitochondrial localisation of frataxin and its association with IscU1 during enterocyte-like differentiation of the human colon adenocarcinoma cell line Caco-2. J Cell Sci 118: 3917-3924.
8. Condo I, Malisan F, Guccini I, Serio D, Rufini A, et al. (2010) Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxin. Hum Mol Genet 19: 1221-1229.
9. Condo I, Ventura N, Malisan F, Rufini A, Tomassini B, et al. (2007) In vivo maturation of human frataxin. Hum Mol Genet 16: 1534-1540.
10. Condo I, Ventura N, Malisan F, Tomassini B, Testi R, (2006) A pool of extramitochondrial frataxin that promotes cell survival. J Biol Chem 281: 16750-16756.
11. Li K, Tong WH, Hughes RM, Rouault TA, (2006) Roles of the mammalian cytosolic cysteine desulfurase, ISCS, and scaffold protein, ISCU, in iron-sulfur cluster assembly. J Biol Chem 281: 12344-12351.
12. Tong WH, Rouault T, (2000) Distinct iron-sulfur cluster assembly complexes exist in the cytosol and mitochondria of human cells. EMBO J 19: 5692-5700.
13. Tong WH, Rouault TA, (2006) Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis. Cell Metab 3: 199-210.
14. Tsai CL, Barondeau DP, (2010) Human frataxin is an allosteric switch that activates the Fe-S cluster biosynthetic complex. Biochemistry 49: 9132-9139.
15. Schmucker S, Martelli A, Colin F, Page A, Wattenhofer-Donze M, et al. (2011) Mammalian frataxin: an essential function for cellular viability through an interaction with a preformed ISCU/NFS1/ISD11 iron-sulfur assembly complex. PLoS One 6: e16199.
16. Prischi F, Konarev PV, Iannuzzi C, Pastore C, Adinolfi S, et al. (2010) Structural bases for the interaction of frataxin with the central components of iron-sulphur cluster assembly. Nat Commun 1: 95.
17. Shan Y, Napoli E, Cortopassi G, (2007) Mitochondrial frataxin interacts with ISD11 of the NFS1/ISCU complex and multiple mitochondrial chaperones. Hum Mol Genet 16: 929-941.
18. Land T, Rouault TA, (1998) Targeting of a human iron-sulfur cluster assembly enzyme, nifs, to different subcellular compartments is regulated through alternative AUG utilization. Mol Cell 2: 807-815.
19. Michael S, Petrocine SV, Qian J, Lamarche JB, Knutson MD, et al. (2006) Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia. Cerebellum 5: 257-267.
20. Ristow M, Pfister MF, Yee AJ, Schubert M, Michael L, et al. (2000) Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proc Natl Acad Sci U S A 97: 12239-12243.
21. Li K, Besse EK, Ha D, Kovtunovych G, Rouault TA, (2008) Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia. Hum Mol Genet 17: 2265-2273.
22. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, et al. (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271: 1423-1427.
23. Selak MA, Lyver E, Micklow E, Deutsch EC, Onder O, et al. (2011) Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function. Mitochondrion 11: 342-350.
24. Schmucker S, Argentini M, Carelle-Calmels N, Martelli A, Puccio H, (2008) The in vivo mitochondrial two-step maturation of human frataxin. Hum Mol Genet 17: 3521-3531.
25. Gakh O, Bedekovics T, Duncan SF, Smith DYt, Berkholz DS, et al. (2010) Normal and Friedreich ataxia cells express different isoforms of frataxin with complementary roles in iron-sulfur cluster assembly. J Biol Chem 285: 38486-38501.
26. Navarro JA, Llorens JV, Soriano S, Botella JA, Schneuwly S, et al. (2011) Overexpression of human and fly frataxins in Drosophila provokes deleterious effects at biochemical, physiological and developmental levels. PLoS One 6: e21017.
27. Velasco-Sanchez D, Aracil A, Montero R, Mas A, Jimenez L, et al. (2011) Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia. Cerebellum 10: 1-8.
28. Yoon T, Dizin E, Cowan JA, (2007) N-terminal iron-mediated self-cleavage of human frataxin: regulation of iron binding and complex formation with target proteins. J Biol Inorg Chem 12: 535-542.
29. Huang J, Dizin E, Cowan JA, (2008) Mapping iron binding sites on human frataxin: implications for cluster assembly on the ISU Fe-S cluster scaffold protein. J Biol Inorg Chem 13: 825-836.
30. Marelja Z, Stocklein W, Nimtz M, Leimkuhler S, (2008) A novel role for human Nfs1 in the cytoplasm: Nfs1 acts as a sulfur donor for MOCS3, a protein involved in molybdenum cofactor biosynthesis. J Biol Chem 283: 25178-25185.
31. Pandolfo M, (2009) Friedreich ataxia: the clinical picture. J Neurol 256 (Suppl 1):: 3-8.
32. Boehm T, Scheiber-Mojdehkar B, Kluge B, Goldenberg H, Laccone F, et al. (2011) Variations of frataxin protein levels in normal individuals. Neurol Sci 32: 327-330.
33. Rai M, Soragni E, Chou CJ, Barnes G, Jones S, et al. (2010) Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model. PLoS One 5: e8825.
34. Nachbauer W, Wanschitz J, Steinkellner H, Eigentler A, Sturm B, et al. (2011) Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia. Mov Disord 26: 1935-1938.
35. Coppola G, Burnett R, Perlman S, Versano R, Gao F, et al. (2011) A gene expression phenotype in lymphocytes from Friedreich ataxia patients. Ann Neurol 70: 790-804.
36. Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, et al. (1997) Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 6: 1771-1780.
37. Al-Mahdawi S, Pinto RM, Ismail O, Varshney D, Lymperi S, et al. (2008) The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues. Hum Mol Genet 17: 735-746.
38. Meyron-Holtz EG, Ghosh MC, Iwai K, LaVaute T, Brazzolotto X, et al. (2004) Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J 23: 386-395.
39. Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, et al. (1997) Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 17: 215-217.
40. Bradley JL, Blake JC, Chamberlain S, Thomas PK, Cooper JM, et al. (2000) Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum Mol Genet 9: 275-282.
41. Pennell DJ, Carpenter JP, Roughton M, Cabantchik Z, (2011) On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure. J Cardiovasc Magn Reson 13: 45.
42. Marobbio CM, Pisano I, Porcelli V, Lasorsa FM, Palmieri L, (2012) Rapamycin reduces oxidative stress in frataxin-deficient yeast cells. Mitochondrion 12: 156-161.
43. Lauhon CT, Kambampati R, (2000) The iscS gene in Escherichia coli is required for the biosynthesis of 4-thiouridine, thiamin, and NAD. J Biol Chem 275: 20096-20103.
44. Meyron-Holtz EG, Ghosh MC, Rouault TA, (2004) Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo. Science 306: 2087-2090.